Comparison of the Cognitive and Motor Effects of Treatment Between an Immediate- and Extended-release Tacrolimus (Envarsus XR) Based Immunosuppression Regimen in Kidney Transplant Recipients
Phase of Trial: Phase I/II
Latest Information Update: 05 Nov 2019
Price : $35 *
At a glance
- Drugs Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 02 May 2019 Planned End Date changed from 1 Mar 2019 to 1 Mar 2020.
- 02 May 2019 Planned primary completion date changed from 1 Mar 2019 to 1 Mar 2020.
- 30 May 2018 Status changed from not yet recruiting to recruiting.